Risk of bleeding events among patients with systemic sclerosis and the general population in the UK: a large population-based cohort study

ConclusionOur results are consistent with a moderately increased risk of bleeding in SSc patients. Further evidence from large SSc patient cohorts is needed to confirm this finding.Key Points•The risk of experiencing a major bleed may be higher among patients with SSc than the general population.•Further large and well-designed studies are needed to corroborate our findings.
Source: Clinical Rheumatology - Category: Rheumatology Source Type: research